Precision Preoperative Embolization of Pelvic Tumors to Improve Surgical Outcomes
Embolization, Pelvic Tumor
About this trial
This is an interventional treatment trial for Embolization
Eligibility Criteria
Inclusion Criteria: Primary or metastatic pelvic tumor Confirmed by contrast-enhanced magnetic resonance imaging (MRI) or computed tomography (CT) of the pelvic Planned surgical resection Exclusion Criteria: Contrast medium allergy Uncontrolled or concurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Precision preoperative embolization
Control group
60 patients with pelvic tumors will undergo arteriography and receive transcatheter arterial embolization of pelvic tumors 0-24 hours prior to surgery.
60 patients with pelvic tumors will undergo arteriography and without transcatheter arterial embolization of pelvic tumors prior to surgery.